M.D.C. Holdings, Inc. (NYSE:MDC) was the recipient of unusually large options trading on Thursday. Stock traders acquired 2,863 call options on the company. This represents an increase of approximately 2,005% compared to the typical volume of 136 call options.

Several research firms have recently commented on MDC. Wedbush increased their target price on M.D.C. from $35.00 to $41.00 and gave the company a “neutral” rating in a research note on Friday, September 13th. ValuEngine cut M.D.C. from a “hold” rating to a “sell” rating in a research note on Thursday, October 31st. Raymond James upgraded M.D.C. from an “outperform” rating to a “strong-buy” rating and increased their target price for the company from $42.00 to $49.00 in a research note on Friday, September 13th. Cfra upgraded M.D.C. from a “hold” rating to a “buy” rating in a research note on Thursday, October 31st. Finally, Zelman & Associates cut M.D.C. from a “buy” rating to a “hold” rating in a research note on Thursday, October 31st. One analyst has rated the stock with a sell rating, three have given a hold rating, one has given a buy rating and two have given a strong buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus price target of $44.00.

In other news, Director Michael A. Berman sold 10,000 shares of the stock in a transaction that occurred on Thursday, September 5th. The stock was sold at an average price of $70.52, for a total transaction of $705,200.00. Following the completion of the transaction, the director now directly owns 148,218 shares in the company, valued at approximately $10,452,333.36. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Raymond T. Baker sold 41,250 shares of the stock in a transaction that occurred on Wednesday, September 18th. The shares were sold at an average price of $42.69, for a total value of $1,760,962.50. Following the transaction, the director now owns 45,462 shares of the company’s stock, valued at $1,940,772.78. The disclosure for this sale can be found here. In the last 90 days, insiders sold 98,832 shares of company stock valued at $4,248,023. 26.30% of the stock is owned by company insiders.

A number of hedge funds and other institutional investors have recently modified their holdings of the business. Acorn Advisory Capital L.P. acquired a new stake in M.D.C. in the third quarter worth $1,375,000. BBVA USA Bancshares Inc. acquired a new stake in M.D.C. in the third quarter worth $702,000. Mason Street Advisors LLC increased its position in M.D.C. by 2.4% in the third quarter. Mason Street Advisors LLC now owns 16,830 shares of the construction company’s stock worth $725,000 after buying an additional 402 shares during the period. Tower Research Capital LLC TRC acquired a new stake in M.D.C. in the third quarter worth $79,000. Finally, SG Americas Securities LLC acquired a new stake in M.D.C. in the third quarter worth $453,000. 74.50% of the stock is currently owned by hedge funds and other institutional investors.

Shares of NYSE MDC opened at $37.55 on Friday. M.D.C. has a 1-year low of $25.77 and a 1-year high of $46.84. The company has a debt-to-equity ratio of 0.66, a current ratio of 9.08 and a quick ratio of 1.83. The business’s fifty day moving average price is $42.86 and its two-hundred day moving average price is $36.86. The firm has a market capitalization of $2.35 billion, a PE ratio of 10.23, a P/E/G ratio of 1.04 and a beta of 1.04.

M.D.C. (NYSE:MDC) last issued its earnings results on Wednesday, October 30th. The construction company reported $0.79 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.87 by ($0.08). M.D.C. had a return on equity of 12.73% and a net margin of 6.58%. The company had revenue of $750.27 million during the quarter, compared to analyst estimates of $767.23 million. During the same period in the prior year, the business earned $0.86 earnings per share. M.D.C.’s quarterly revenue was down 2.1% on a year-over-year basis. Equities research analysts expect that M.D.C. will post 3.54 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Wednesday, November 27th. Shareholders of record on Wednesday, November 13th will be given a $0.30 dividend. This represents a $1.20 annualized dividend and a yield of 3.20%. The ex-dividend date of this dividend is Tuesday, November 12th. M.D.C.’s dividend payout ratio is presently 32.70%.

M.D.C. Company Profile

M.DC Holdings, Inc, through its subsidiaries, engages in the homebuilding and financial service businesses. Its homebuilding operations include purchasing finished lots or developing lots for the construction and sale primarily of single-family detached homes to first-time and first-time move-up homebuyers under the Richmond American Homes name.

Recommended Story: What is a Lock-Up Period?

Receive News & Ratings for M.D.C. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for M.D.C. and related companies with MarketBeat.com's FREE daily email newsletter.